Global Investor Ideas - stock market news and investing podcasts for your next trading ideas
Global Investor Ideas - breaking stock market news and investing ideas
Featured Company:
Aethlon Medical, Inc. (NASDAQ: AEMD) is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and harmful exosomes from blood utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Get news alerts on this company!
March 13, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, is on the NASDAQ top ten gainers list today trading at…
March 12, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, made…
Transportation Stocks on the Move: (Nasdaq:DUOT) (Nasdaq:RVSN) (NYSE:ASC) March 11, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in…
March 8, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Psyence Biomedical Ltd (NASDAQ:PBM) recently announced that its wholly-owned subsidiary, Psyence Australia (Pty) Ltd (“Psyence Australia”), has received full approval…
March 7, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company announced the interim topline results confirming…
March 6, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – NKGen Biotech, Inc. (NASDAQ: NKGN) made the top percentage gainers liston NASDAQ today, trading at $2.1800, up $1.2582 or 136.4938%mon…
Focus on Biotech Stocks: (Nasdaq:GUTS) (NYSE:ANRO) (Nasdaq:KYTX) (Nasdaq:BYSI) March 6, 2024 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in…
A Race worth Winning March 6, 2024 Globalinvestorideas.com, a global investor news source covering biotech and pharma stocks issues a sector snapshot on developments for pancreatic cancer treatments, featuring Oncolytics…
Biotech Stock Additions: (Nasdaq:TELO) (Nasdaq:MGX) (Nasdaq:IMUX) (Nasadq:VTYX) March 4, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the…
February 28, 2024 (Globalinvestorideas.com Newswire) Oncology Stock News Bites – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today provided a corporate and financial update for the fourth quarter…
February 27, 2024 (Globalinvestorideas.com Newswire) Biopharma Stock News Bites – Janux Therapeutics, Inc. (Nasdaq: JANX) a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary…
February 26, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology company reported financial results and key business updates for the fourth quarter…
February 22, 2024 (Globalinvestorideas.com Newswire) Investorideas.com (www.investorideas.com) Biotech Stock News Bites – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for…
February 21, 2024 (Globalinvestorideas.com Newswire) Investorideas.com (www.investorideas.com) Biotech Stock News Bites- Ventyx Biosciences, Inc. (NASDAQ: VTYX) makes the NASDAQ list of one of the top percentage gainers as the stock…
Aethlon Medical Will Perform Pre-Clinical Studies to Explore Potential Synergies With its First-in-Class Hemopurifier® Blood Filtration System SAN DIEGO – February 21, 2024 (Gloablinvestorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD),…
Stocks to Watch in Tech & Cybersecurity – (Nasdaq:KSPI) (Nasdaq:CCTG) (Nasdaq:HUBC) (Nasdaq:GEN) February 21, 2024 (Globalinvestorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of…
Life Sciences Stocks to Watch: (NASDAQ:ACHV) (NASDAQ:NRBO) (Nasdaq:BTSG) (NASDAQ:AIMD) February 16, 2024 (Globalinvestorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch…
Stock Trades up over 28% on News February 15, 2024 (Globalinvestorideas.com Newswire) Investorideas.com (www.investorideas.com) Life Sciences Stock News Bites- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) , a clinical-stage life…
Tapping into Immune Systems for Next Generation Treatments February 15, 2024 Investorideas.com, a global investor news source covering biotech and pharma stocks issues a sector snapshot on cancer immunotherapy featuring…
Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO – February 14, 2024 (Globalinvestorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing…